FDA and CDC Sign Off on Pfizer Booster Shots for Seniors 65-Plus for Extra Protection Against the COVID Virus - AMAC - The Association of Mature American Citizens

4 min read
The advisory panel did not vote on booster shots for people who received the Moderna and Johnson & Johnson vaccines. But the New York Times r
WASHINGTON, DC, Sep 24 — The Centers for Disease Control [CDC] says Americans 65 and older, as well as those at risk due to their medical histories, can begin getting booster shots for the Pfizer-BioNTech coronavirus vaccine. "We encourage our members and all eligible seniors to consider the benefits, not the least of which is a healthier life in our golden years," says Rebecca Weber, CEO of the Association of Mature American Citizens [AMAC].

The Food and Drug Administration's advisory committee voted unanimously on Wednesday to authorize a third dose of the vaccine for seniors and individuals who may be at risk and who received double doses of the vaccine six months ago. And, today, CDC scientific advisers voted 15-0 to begin providing third dose inoculations as soon as Director Rochelle Walensky signs off.

The advisers also voted 13-2 in favor of third shots for at-risk seniors between the ages of 50 and 64. A majority also approved shots for adults aged 18 to 49 years with underlying medical conditions.

eports that the advisors discussed "a mix-and-match strategy and signaled that they would revisit the issue as new data emerge." And, according to the Times, once the director makes it official, "anyone who wants a booster may simply be able to walk into a pharmacy and ask for one — many Americans already did so before the FDA's authorization, typically by finding a cooperative pharmacist or pretending to be…
Amac, John Grimaldi, Leland Stuper
Read full article